Cationic polymer precipitation for enhanced impurity removal in downstream processing
Biotechnology and Bioengineering · 2023
DOI: 10.1002/bit.28416 ↗At a glance
Journal article in Biotechnology and Bioengineering, 2023. Written by Zhao Li and 6 co-authors. Institution: Biologics Process Development, Biologics Process Research and Development, Merck & Co., Inc., Rahway, New Jersey, USA. Major MEDLINE topics: Polymers, Biological Products. Cited 8 times so far (Crossref); 31 references. Funded by: Merck.
Abstract (original language)
Precipitation can be used for the removal of impurities early in the downstream purification process of biologics, with the soluble product remaining in the filtrate through microfiltration. The objective of this study was to examine the use of polyallylamine (PAA) precipitation to increase the purity of product via higher host cell protein removal to enhance polysorbate excipient stability to enable a longer shelf life. Experiments were performed using three monoclonal antibodies (mAbs) with different properties of isoelectric point and IgG subclass. High throughput workflows were established to quickly screen precipitation conditions as a function of pH, conductivity and PAA concentrations. Process analytical tools (PATs) were used to evaluate the size distribution of particles and inform the optimal precipitation condition. Minimal pressure increase was observed during depth filtration of the precipitates. The precipitation was scaled up to 20L size and the extensive characterization of precipitated samples after protein A chromatography showed >75% reduction of host cell protein (HCP) concentrations (by ELISA), >90% reduction of number of HCP species (by mass spectrometry), and >99.8% reduction of DNA. The stability of polysorbate containing formulation buffers for all three mAbs in the protein A purified intermediates was improved at least 25% after PAA precipitation. Mass spectrometry was used to obtain additional understanding of the interaction between PAA and HCPs with different properties. Minimal impact on product quality and
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Biologics Process Development, Biologics Process Research and Development, Merck & Co., Inc., Rahway, New Jersey, USA.
- Biologics Analytical Research and Development, Merck & Co., Inc., Rahway, New Jersey, USA.
- Analytical Research and Development Mass Spectrometry, Merck & Co., Inc., Rahway, New Jersey, USA.
ORCID profiles: Zhao Li, John Welsh
Funding
- Merck
Cite
APA
Li, Z., Chen, J., Martinez-Fonts, K., Rauscher, M., Rivera, S., Welsh, J., & Kandula, S. (2023). Cationic polymer precipitation for enhanced impurity removal in downstream processing. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28416
Vancouver
Li Z, Chen J, Martinez-Fonts K, Rauscher M, Rivera S, Welsh J, et al. Cationic polymer precipitation for enhanced impurity removal in downstream processing. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28416
BibTeX
@article{Li2023,
author = {Li, Zhao and Chen, Justin and Martinez-Fonts, Kirby and Rauscher, Michael and Rivera, Shannon and Welsh, John and Kandula, Sunitha},
title = {Cationic polymer precipitation for enhanced impurity removal in downstream processing},
journal = {Biotechnology and Bioengineering},
year = {2023},
doi = {10.1002/bit.28416}
}
EUVIMED